Inactive Instrument

Sector Chart Catabasis Pharmaceuticals Inc Nasdaq

Equities

US14875P1075

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
106B
24.28B -
21.96B -
18.16B
16.37B